Patent debate -- MIDRANGE-NONTECH

Subject: Patent debate
From: Randy Mangham <randy.mangham@xxxxxxxx>
Date: Sun, 09 Sep 2001 09:22:47 -0700
List-Archive: <http://archive.midrange.com/midrange-nontech/>
List-Help: <mailto:midrange-nontech-request@midrange.com?subject=help>
List-Id: Non-Technical Discussion about the AS400 / iSeries <midrange-nontech.midrange.com>
List-Post: <mailto:midrange-nontech@midrange.com>
List-Subscribe: <http://lists.midrange.com/cgi-bin/listinfo/midrange-nontech>,<mailto:midrange-nontech-request@midrange.com?subject=subscribe>
List-Unsubscribe: <http://lists.midrange.com/cgi-bin/listinfo/midrange-nontech>,<mailto:midrange-nontech-request@midrange.com?subject=unsubscribe>

I certainly don't want to rekindle the debate over whether companies get
patents just to freeze the marketplace but here is an interesting NY Times
article on IBM's research labs and how much cross licensing revenue their
patents bring into IBM. It's worth reading.

http://www.nytimes.com/2001/09/09/business/09IBMM.html?todaysheadlines

Randy Mangham
Pacific Crest Consulting
San Diego CA

As an Amazon Associate we earn from qualifying purchases.

Follow-Ups:

Re: Patent debate , Chris Rehm

This mailing list archive is Copyright 1997-2024 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].

Operating expenses for this site are earned using the Amazon Associate program and Google Adsense.